We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Thryv Holdings
THRY
$184M
| $502K | 0.01% |
+41,272
| New | +$533K |
|
|
RDUS
1202
DELISTED
Radius Recycling
RDUS
| $502K | 0.01% |
+16,893
| New | +$496K |
|
1203
Lakeland Financial Corp
LKFN
$1.57B
| $498K | 0.01% |
8,099
-5,818
| -42% | -$338K |
|
1204
Disc Medicine
IRON
$2.81B
| $497K | 0.01% |
+9,382
| New | +$441K |
|
1205
Tactile Systems Technology
TCMD
$618M
| $497K | 0.01% |
+48,976
| New | +$559K |
|
1206
Tronox
TROX
$967M
| $495K | 0.01% |
+97,620
| New | +$531K |
|
1207
Lumentum
LITE
$46.9B
| $494K | 0.01% |
5,200
-14,633
| -74% | -$1.04M |
|
1208
Arrowhead Research
ARWR
$12.1B
| $491K | 0.01% |
+31,105
| New | +$446K |
|
1209
ORIX
IX
$42.7B
| $489K | 0.01% |
+21,735
| New | +$446K |
|
|
BRKL
1210
DELISTED
Brookline Bancorp
BRKL
| $488K | 0.01% |
+46,292
| New | +$481K |
|
1211
Transportadora de Gas del Sur
TGS
$4.48B
| $488K | 0.01% |
+18,837
| New | +$516K |
|
1212
Roper Technologies
ROP
$40.4B
| $486K | 0.01% |
+858
| New | +$485K |
|
1213
Aspen Aerogels
ASPN
$339M
| $484K | 0.01% |
+81,684
| New | +$470K |
|
1214
Genius Sports
GENI
$1.95B
| $483K | 0.01% |
46,453
-28,358
| -38% | -$283K |
|
1215
Rithm Capital
RITM
$5.58B
| $483K | 0.01% |
42,742
-32,023
| -43% | -$353K |
|
1216
Goosehead Insurance
GSHD
$2.51B
| $482K | 0.01% |
4,571
+1,612
| +54% | +$171K |
|
1217
AerSale
ASLE
$291M
| $481K | 0.01% |
+80,087
| New | +$513K |
|
1218
Customers Bancorp
CUBI
$2.66B
| $480K | 0.01% |
+8,176
| New | +$414K |
|
1219
Cosan
CSAN
$3.02B
| $480K | 0.01% |
+95,092
| New | +$513K |
|
1220
Schwab US Mid-Cap ETF
SCHM
$14.2B
| $478K | 0.01% |
+17,037
| New | +$449K |
|
1221
DigitalOcean
DOCN
$12.5B
| $478K | 0.01% |
+16,723
| New | +$488K |
|
1222
Janux Therapeutics
JANX
$912M
| $476K | 0.01% |
20,602
+2,769
| +16% | +$73K |
|
1223
Brady Corp
BRC
$4.46B
| $475K | 0.01% |
+6,990
| New | +$487K |
|
1224
Trevi Therapeutics
TRVI
$2.57B
| $475K | 0.01% |
+86,830
| New | +$540K |
|
1225
Global X NASDAQ-100 Covered Call ETF
QYLD
$7.88B
| $474K | 0.01% |
+28,351
| New | +$463K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.